1. Long Non-Coding RNAs in Drug Resistance of Breast Cancer


    Tonghua Du et al, 2020, OncoTargets and Therapy CrossRef
  2. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
    Jin-hai Tian et al, 2021, Frontiers in Oncology CrossRef
  3. Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
    Andrea Kapinova et al, 2023, EPMA Journal CrossRef
  4. Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer
    Paul Holvoet, 2021, Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer CrossRef
  5. UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer
    Jun-Yi Yin et al, 2024, Current Cancer Drug Targets CrossRef

  6. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis


    Chunhong Liu et al, 2020, Cancer Management and Research CrossRef
  7. Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation
    Zhen Yang et al, 2022, Frontiers in Molecular Biosciences CrossRef
  8. The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
    Nashmin Fayazi Hosseini et al, 2021, Current Molecular Medicine CrossRef
  9. Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer
    Junyuan Xie et al, 2023, Frontiers in Oncology CrossRef
  10. EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
    Ting Liu et al, 2021, Frontiers in Oncology CrossRef
  11. HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2
    Guolei Dong et al, 2020, BioMed Research International CrossRef
  12. Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer
    Ishaq Tantray et al, 2023, Frontiers in Genetics CrossRef
  13. ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer
    Hyeon Woo Kim et al, 2023, Epigenetics CrossRef
  14. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
    Jianwei Feng et al, 2022, Frontiers in Pharmacology CrossRef
  15. UCA1 Overexpression Promotes Hypoxic Breast Cancer Cell Proliferation and Inhibits Apoptosis via HIF-1α Activation
    Hani Choudhry et al, 2021, Journal of Oncology CrossRef
  16. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
    Dharambir Kashyap et al, 2023, Frontiers in Genetics CrossRef
  17. The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers
    Zahra Abedi kichi et al, 2022, Current Medicinal Chemistry CrossRef
  18. Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
    Irina V. Bure et al, 2022, International Journal of Molecular Sciences CrossRef
  19. microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway
    Ying Zhang et al, 2023, Apoptosis CrossRef
  20. Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer
    Huan Chen et al, 2023, Functional & Integrative Genomics CrossRef